Eureka Nanobioengineering offers a proprietary platform for the creation of nanobiodevices and advanced functional nanobiomaterials.
Eureka Nanobioengineering has raised $250K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2023.
Eureka Nanobioengineering's investors include SF500.
Eureka Nanobioengineering is headquartered in Villa Lynch, Argentina.
Eureka Nanobioengineering offers a proprietary platform for the creation of nanobiodevices and advanced functional nanobiomaterials.
Eureka Nanobioengineering is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eureka Nanobioengineering — Funding & Investors." VCBacked, January 1, 2023, https://www.vcbacked.co/company/eureka-nanobioengineering. Accessed August 14, 2026.
VCBacked. (2023). Eureka Nanobioengineering — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/eureka-nanobioengineering
{{cite web |title=Eureka Nanobioengineering — Funding & Investors |url=https://www.vcbacked.co/company/eureka-nanobioengineering |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated